Changes in Efficacy Indicators for Adalimumab Biosimilar Candidate (HS016) for the Treatment of Active Ankylosing Spondylitis at Various Time Points by Jinmei Su, Mengtao Li, Lan He, Dongbao Zhao, Weiguo Wan, Yi Liu, Jianhua Xu, Jian Xu, Huaxiang Liu, Lindi Jiang, Huaxiang Wu, Xiaoxia Zuo, Cibo Huang, Xiumei Liu, Fen Li, Zhiyi Zhang, Xiangyuan Liu, Lingli Dong, Tianwang Li, Haiying Chen, Jingyang Li, Dongyi He, Xin Lu, Anbin Huang, Yi Tao, Yanyan Wang, Zhuoli Zhang, Wei Wei, Xiaofeng Li, Xiaofeng Zeng

Connect to this object online.